文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

美国青少年和成人COVID-19二价加强针接种覆盖率及接种意愿,2022年11月至12月

COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults - United States, November-December 2022.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2023-02-17

基于2022年10月30日至12月31日美国国家免疫调查数据,完成基础免疫的12-17岁青少年中18.5%已接种二价加强针,成人中27.1%已接种。农村地区基础免疫完成率和最新接种覆盖率均较低,非西班牙裔黑人和西班牙裔接种覆盖率低于非西班牙裔白人。开放接种者中较多未获提供者推荐。

要点

  • 完成基础免疫的青少年中18.5%已接种二价加强针,52.0%的家长开放接种。
  • 完成基础免疫的成人中27.1%已接种二价加强针,39.4%开放接种。
  • 农村地区基础免疫完成率和最新接种覆盖率均较低。

核心结论

  • 完成基础免疫的青少年和成人中二价加强针覆盖率分别为18.5%和27.1%,相当比例开放接种但尚未接种。
  • 农村地区基础免疫完成率和最新接种覆盖率较低,非西班牙裔黑人和西班牙裔青少年及成人二价加强针覆盖率低于非西班牙裔白人。

研究设计与样本

  • 基于2022年10月30日至12月31日收集的国家免疫调查-儿童COVID模块(NIS-CCM)和国家免疫调查-成人COVID模块(NIS-ACM)数据。
  • 分析对象为完成COVID-19基础免疫的12-17岁青少年和≥18岁成人。

主要发现

  • 12-17岁完成基础免疫青少年中,18.5%已接种二价加强针,52.0%未接种但家长开放接种,15.1%家长不确定,14.4%家长不愿寻求接种。
  • 完成基础免疫成人中,27.1%已接种二价加强针,39.4%未接种但开放接种,12.4%不确定,21.1%不愿接种。
  • 开放接种的成人中,58.9%未获提供者推荐,16.9%有安全担忧,4.4%获取疫苗困难。
  • 开放为子女接种的青少年家长中,32.4%未获任何COVID-19疫苗接种的提供者推荐,11.8%有安全担忧。
  • 成人二价加强针覆盖率因收入、保险状况和社会脆弱指数(SVI)等因素而异,但这些因素与不愿寻求接种无关。

关键数值与推荐

  • CDC于2022年9月1日推荐12-17岁青少年和≥18岁成人接种更新(二价)加强针。
  • 二价加强针针对Omicron BA.4和BA.5亚型及原始株配制。

临床怎么用

  • 提供者推荐COVID-19疫苗接种;由可信信使传播COVID-19相关疾病持续风险及二价加强针益处和安全性信息;减少接种障碍,可能提高青少年和成人二价加强针覆盖率。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

COVID-19 vaccine booster doses are safe and maintain protection after receipt of a primary vaccination series and reduce the risk for serious COVID-19-related outcomes, including emergency department visits, hospitalization, and death (1,2). CDC recommended an updated (bivalent) booster for adolescents aged 12-17 years and adults aged ≥18 years on September 1, 2022 (3). The bivalent booster is formulated to protect against the Omicron BA.4 and BA.5 subvariants of SARS-CoV-2 as well as the original (ancestral) strain (3). Based on data collected during October 30-December 31, 2022, from the National Immunization Survey-Child COVID Module (NIS-CCM) (4), among all adolescents aged 12-17 years who completed a primary series, 18.5% had received a bivalent booster dose, 52.0% had not yet received a bivalent booster but had parents open to booster vaccination for their child, 15.1% had not received a bivalent booster and had parents who were unsure about getting a booster vaccination for their child, and 14.4% had parents who were reluctant to seek booster vaccination for their child. Based on data collected during October 30-December 31, 2022, from the National Immunization Survey-Adult COVID Module (NIS-ACM) (4), 27.1% of adults who had completed a COVID-19 primary series had received a bivalent booster, 39.4% had not yet received a bivalent booster but were open to receiving booster vaccination, 12.4% had not yet received a bivalent booster and were unsure about getting a booster vaccination, and 21.1% were reluctant to receive a booster. Adolescents and adults in rural areas had a much lower primary series completion rate and up-to-date vaccination coverage. Bivalent booster coverage was lower among non-Hispanic Black or African American (Black) and Hispanic or Latino (Hispanic) adolescents and adults compared with non-Hispanic White (White) adolescents and adults. Among adults who were open to receiving booster vaccination, 58.9% reported not having received a provider recommendation for booster vaccination, 16.9% had safety concerns, and 4.4% reported difficulty getting a booster vaccine. Among adolescents with parents who were open to getting a booster vaccination for their child, 32.4% had not received a provider recommendation for any COVID-19 vaccination, and 11.8% had parents who reported safety concerns. Although bivalent booster vaccination coverage among adults differed by factors such as income, health insurance status, and social vulnerability index (SVI), these factors were not associated with differences in reluctance to seek booster vaccination. Health care provider recommendations for COVID-19 vaccination; dissemination of information by trusted messengers about the continued risk for COVID-19-related illness and the benefits and safety of bivalent booster vaccination; and reducing barriers to vaccination could improve COVID-19 bivalent booster coverage among adolescents and adults.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Lu PJ, Zhou T, Santibanez TA, et al. COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults - United States, November-December 2022. MMWR Morb Mortal Wkly Rep. 2023. PMID: 36795677. doi:10.15585/mmwr.mm7207a5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。